Erschienen in:
27.05.2019 | Refractive Surgery
Use of low-vault posterior chamber collagen copolymer phakic intraocular lenses for the correction of myopia: a 3-year follow-up
verfasst von:
Khosrow Jadidi, Seyed Aliasghar Mosavi, Farhad Nejat, Neda Mohammadi, Hosein Aghamolaei, Seyed-Hashem Daryabari, Hamidreza Torabi, Aliagha Alishiri
Erschienen in:
Graefe's Archive for Clinical and Experimental Ophthalmology
|
Ausgabe 7/2019
Einloggen, um Zugang zu erhalten
Abstract
Background
Phakic intraocular lens (pIOL) models have indicated an association between cataract formation and inadequate vaulting. In this study, the efficacy and safety of low-vault posterior chamber pIOLs in the correction of myopia were examined over 3 years.
Methods
From 316 patients undergoing surgery, 14 eyes with a low vault (≤ 150 μm) were examined from 14 patients. After implanting the Visian Implantable Collamer pIOL for the correction of myopia (moderate and high), the pIOL vault, endothelial cell loss, uncorrected distance visual acuity (UDVA), corrected DVA (CDVA), and detrimental events were examined over 3 years.
Results
Based on the findings, the mean spherical equivalent reduced from − 8.15 ± 3.29 before surgery to − 1.02 ± 0.75 diopters 3 years after the surgery. In terms of visual outcomes, the mean UDVA (Log MAR) significantly increased from 0.95 ± 037 to 0.27 ± 0.28, and the mean CDVA also increased from 0.99 ± 0.11 to 0.06 ± 0.08 (P < 0.05). The mean indices of safety and efficacy were respectively 1.075 and 0.748. The eyes lost not more than two visual acuity lines. Based on the findings, 82% achieved 0.80 or better CDVA, while the total endothelial cell loss was 7.96% during 3 years. Overall, vision-threatening conditions were not reported.
Conclusion
The introduced pIOL can be considered a safe and efficient method for myopia at moderate to high levels.